CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lexaria Bioscience Corp   (NASDAQ: LEXX)
Other Ticker:  
 


Lexaria Bioscience 's ROA from the first quarter of 2025 to the first quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Lexaria Bioscience 's ROA in the first quarter of 2025?
Lexaria Bioscience Corp recorded a cumulative net loss of $-7 million during 12 months ending in the first quarter of 2025, resulting in a negative return on assets (ROA) of -83.39%.

However, within the Healthcare sector 550 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Nov 30 2024 quarter, so far to 3211, from total ROA ranking in the fourth quarter of 2024 at 4013.

What is ROA?


Return On Assets (Nov 30 2024)
I. Quarter		 (Aug 31 2024)
IV. Quarter		 (May 31 2024)
III. Quarter		 (Feb 29 2024)
II. Quarter		 (Nov 30 2023)
I. Quarter
Y / Y Total Assets Change 171.8 % 189.61 % 91.2 % 30.84 % -41.63 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -7 -6 -7 -7 -8
Return On Assets (TTM) -83.39 % -80.32 % -115.08 % -158.22 % -187.98 %
LEXX's Total Ranking # 3211 # 4013 # 4281 # 4485 # 4783
Total Assets (TTM) in million 10 9 10 6 4
Seq. Total Assets Change 10.37 % -10.85 % 57.72 % 75.14 % 17.6 %
Seq. Net Income Change - - - - -

LEXX's 5 Years Annual ROA >> Back to LEXX Management Effectiveness >> Compare LEXX ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 243
Sector # 551
Overall # 3210

Return On Assets Statistics
High Average Low
-9.84 %
-124.53 %
-251.48 %
(Nov 30 2021)   (Aug 31 2018)





Financial Statements
Lexaria Bioscience 's Assets $ 10 million LEXX's Balance sheet
Lexaria Bioscience 's Income $ -3 million Quarterly LEXX's Income Statement
LEXX's Income by Division See LEXX's Income by Division



Annual Return On Assets (Aug 31 2024)
FY 2024		 (Aug 31 2023)
FY 2023		 (Aug 31 2022)
FY 2022		 (Aug 31 2021)
FY 2021		 (Aug 31 2020)
FY 2020
Y / Y Total Assets Change 189.61 % -60.63 % -40.95 % 369.09 % 17.35 %
Total Assets in million 9 3 8 13 3
Y / Y Net Income Change - - - - -
Net Income in million -6 -7 -7 -4 -4
Annual Return On Assets -65.04 % -217.66 % -91.33 % -29.15 % -133.77 %

LEXX's 5 Years Annual ROA >> Back to LEXX Management Effectiveness >> Compare LEXX ROA to its Competitors



More Return On Assets Ratios
LEXX's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LEXX's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Roa for LEXX's Competitors
Roa for Lexaria Bioscience 's Suppliers
Return On Assets for LEXX's Customers

You may also want to know
LEXX's Roi LEXX's Inventory Turnover Ratio LEXX's Growth Rates LEXX's Dividend Comparisons
LEXX's Profitability Ratios LEXX's Asset Turnover Ratio LEXX's Dividend Growth
LEXX's Roe LEXX's Valuation Ratios LEXX's Financial Strength Ratios LEXX's Dividend Payout Ratio



Companies with similar Return On Assets at Nov 30 2024, within Healthcare Sector ROA

Date modified: 2025-01-13T18:09:10+00:00


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com